Search research articles
Contact Us
Filters
Showing results (401-410 of 768) with videos related to
Page
of 77
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2009
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes
Koen van Besien, Jeanette Carreras, Philip J Bierman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 8, 2009
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation
Jonas A de Souza, Rima M Saliba, Poliana Patah, et al.
International Journal of Hematology
|
December 10, 2009
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
Yee Chung Cheng, Gabriela Rondón, Leah F Sanchez, et al.
Bone Marrow Transplantation
|
December 12, 2018
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS
Gheath Alatrash, Kelly M Kidwell, Peter F Thall, et al.
Leukemia Research Reports
|
July 4, 2025
Tagraxofusp maintenance post-hematopoietic stem cell transplantation provides long-term survival and manageable safety for a patient with blastic plasmacytoid dendritic cell neoplasm
Qaiser Bashir, Marina Konopleva, Glorette Abueg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2014
Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning
Christopher G Kanakry, Paul V O'Donnell, Terry Furlong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2002
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma
C Hosing, M Munsell, S Yazji, et al.
Leukemia & Lymphoma
|
October 26, 2011
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant
Qaiser Bashir, Mark F Munsell, Sergio Giralt, et al.
Leukemia & Lymphoma
|
January 17, 2012
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant
Amer M Beitinjaneh, Rima Saliba, Qaiser Bashir, et al.
Bone Marrow Transplantation
|
June 27, 2006
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
P Kebriaei, R M Saliba, C Ma, et al.
Page
of 77
Search research articles
Search
Showing results (401-410 of 768) with videos related to
Sort By:
Page
of 77
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2009
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes
Koen van Besien, Jeanette Carreras, Philip J Bierman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 8, 2009
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation
Jonas A de Souza, Rima M Saliba, Poliana Patah, et al.
International Journal of Hematology
|
December 10, 2009
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
Yee Chung Cheng, Gabriela Rondón, Leah F Sanchez, et al.
Bone Marrow Transplantation
|
December 12, 2018
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS
Gheath Alatrash, Kelly M Kidwell, Peter F Thall, et al.
Leukemia Research Reports
|
July 4, 2025
Tagraxofusp maintenance post-hematopoietic stem cell transplantation provides long-term survival and manageable safety for a patient with blastic plasmacytoid dendritic cell neoplasm
Qaiser Bashir, Marina Konopleva, Glorette Abueg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2014
Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning
Christopher G Kanakry, Paul V O'Donnell, Terry Furlong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2002
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma
C Hosing, M Munsell, S Yazji, et al.
Leukemia & Lymphoma
|
October 26, 2011
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant
Qaiser Bashir, Mark F Munsell, Sergio Giralt, et al.
Leukemia & Lymphoma
|
January 17, 2012
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant
Amer M Beitinjaneh, Rima Saliba, Qaiser Bashir, et al.
Bone Marrow Transplantation
|
June 27, 2006
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
P Kebriaei, R M Saliba, C Ma, et al.
Page
of 77